Iohexol prescribing information
WebYou need to enable JavaScript to run this app. WebDisclaimer: This information is independently developed by CIMS based on iohexol from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information.
Iohexol prescribing information
Did you know?
WebOMNIPAQUE 300 contains 647 mg of iohexol equivalent to 300 mg of organic iodine per mL; and OMNIPAQUE 350 contains 755 mg of iohexol equivalent to 350 mg of organic iodine per mL. Each milliliter of iohexol solution contains 1.21 mg tromethamine and 0.1 mg edetate calcium disodium with the pH adjusted between 6.8 and 7.7 with hydrochloric … Web6 jul. 2007 · Iohexol. DrugBank Accession Number. DB01362. Background. Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. Type.
WebSee full prescribing information for OMNIPAQUE IMAGING BULK PACKAGE. OMNIPAQUE (iohexol) injection, for intra-venous use. Initial U.S. Approval: 1985 …
WebHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LUMOXITI safely and effectively. See full prescribing information for LUMOXITI. LUMOXITI™ (moxetumomab pasudotox-tdfk) for injection, for intravenous use Initial U.S. Approval: 2024 . WARNING: CAPILLARY LEAK … WebHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNIPAQUE safely and effectively. See full prescribing …
Web23 jan. 2024 · Omnipaque Injection Prescribing Information. Package insert / product label Generic name: iohexol Dosage form: injection Drug class: Non-ionic iodinated contrast media. Medically reviewed by …
WebPer 350 mg Iohexol 755 mg/mL (iodine 350 mg/mL) Indications/Uses Radiocontrast medium used for myelography, cardioangiography, arteriography, urography, … greenpea clothingWebPRESCRIBING INFORMATION OMNIPAQUE™ (iohexol) Please refer to full national Summary of Product Characteristics (SPC) before ... PRESENTATION Aqueous solution for injection containing iohexol, a non-ionic, monomeric, triiodinated X-ray contrast medium, and available in strengths containing either 140 mg, 240 mg, 300 mg or 350 mg iodine ... fly screens townsvilleWebOMNIPAQUE (iohexol) injection, for intrathecal, intravascular, oral , rectal, intraarticular, or body cavity use. OMNIPAQUE (iohexol) oral solution . Initial U.S. Approval: 1985 . … fly screens te awamutuWeb8 apr. 2024 · Signs of kidney problems like unable to pass urine, change in how much urine is passed, blood in the urine, or a big weight gain. Injection: Weakness on 1 side of the body, trouble speaking or thinking, change in balance, drooping on one side of the face, or blurred eyesight. Chest pain or pressure. green peacock feathersWebBrown SC, O'Reilly PH: Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard. J Urol 1991;146:675-679. 2. Gaspari F, Perico N, Ruggenenti P, et al: Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995;6:257-263. 3. fly screens tasmaniaWebThe MHRA products website allows you to find: The leaflets which are provided with medicines. The description of the medicinal product’s properties and how it can be used. Scientific reports about marketing authorisations for medicines. You can look for any word, phrase or Product Licence number (PL) using the search tool. green peaches how to ripenWebIohexol Injection is a sterile solution of Iohexol in Water for Injection. It contains NLT 95.0% and NMT 105.0% of the labeled amount of iohexol (C 19 H 26 I 3 N 3 O 9) as organically … fly screens tauranga